Global leaders meet at first-ever UN tuberculosis summit
Governments must act rapidly to expand access to safer, more effective, injection-free treatment regimens
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Bayer initiates public dialogue on tackling vector borne diseases in India
National dialogue on 'Protecting Communities: Vector Control in Action' sees support and participation from key public and private…
FOPE, HDMA members meet DGCI, state regulators
The September 21st meet saw productive discussions on the many recent regulatory changes
TAKE Solutions to receive Golden Peacock Award for excellence in corporate governance
The World Council for Corporate Governance, UK, confers the award annually, to companies that have demonstrated benchmark…
GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults
Publication of primary results in the New England Journal of Medicine shows positive impact of innovative vaccine technology in…
AstraZeneca announces positive results from Phase III DECLARE-TIMI 58
Forxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000…
Dr Manoj Nerurkar, COO steps down from role at Syngene
The announcement of the appointment of his successor will be made shortly
Netmeds strengthens its healthcare expertise with acquisition of JustDoc.com
With this acquisition, Netmeds marks its entry into the diagnostics, offering end-to-end consultancy in the healthcare, lifestyle…
Novartis to cut 2,200 jobs in Switzerland to boost profitability
About 1,500 positions will be cut from Novartis's production sites in Basel, Stein, Locarno and Schweizerhalle
EU approves AstraZeneca immunotherapy drug for lung cancer
The green light from the EU had been expected following a positive recommendation from experts at the European Medicines Agency
USFDA completes inspection of Biocon’s drug substance unit at Bengaluru
The week-long audit concluded without any observations and no Form 483 was issued
Kaisha launches Kaisha Lifesciences at Daman, India
In addition to the products offered by Kaisha Lifesciences, the new set-up will offer a portfolio of contract research services…
Bayer says Monsanto India integration to complete in one year
Bayer completed the deal to acquire US-based Monsanto recently and the acquisition of Monsanto has been completed globally but it…
Cipla receives final approval for generic version of Impax Laboratories, Albenza
It is an anthelmintic drug indicated for use in treatment of parenchymal neurocysticercosis
Biocon and Mylan announce positive CHMP opinion for Fulphila, Biosimilar Pegfilgrastim
Fulphila was approved by the US FDA earlier this year and is the first FDA-approved biosimilar for Neulasta in the US
Centaur Pharma concludes 10th common cold awareness week campaign
Centaur has been undertaking the 'Common Cold Awareness Week' campaign to prevent people from self medication and encourage them…
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharma is to launch a patient support programme to assist patients prescribed with this drug
Schott Kaisha hosts pharma packaging stalwarts at its Jambusar plant, Gujarat
More than 60 delegates took part in the half-day visit to Schott Kaisha’s state-of-the-art facility
GSK grabs new drug development head from Boehringer
GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim
AstraZeneca plots China robot offensive to counter price cuts
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move…